Toggle light / dark theme


AgelessRx claims that PEARL is the first nationwide telemedicine trial and one of the first large-scale intervention trials on Longevity. The human trial is a stepping stone to the way to bringing rapamycin to the Longevity market. PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity) is a $600,000 trial with the University of California. They will evaluate the safety and effectiveness of rapamycin in 200 healthy adults for Longevity in double-blind, randomized, placebo-controlled trial.

Interested patients will be screened for eligibility using telemedicine. Eligible patients include those aged 50–85 of any sex, any ethnicity, in relatively good health, with only well-managed, clinically stable chronic diseases.

TAME is a separate $75 million trial to clinically evaluate Metformin drugs for Longevity properties. TAME has a composite primary endpoint – of stroke, heart failure, dementia, myocardial infarction, cancer and death. Rather than attempting to cure one endpoint, it will look to delay the onset of any endpoint, extending the years in which subjects remain in good health – their healthspan. A $40 million donation has been combined with a $35 million NIH grant to fund the TAME trial.

(next Monday, 23rd November)
Please pre-register at https://www.taufriends.ch/registration

Please pre-register at https://www.taufriends.ch/registration

“We are delighted to bring you access to two giants in the world of AI, 2020 Dan David laureates, Dr. Demis Hassabis, co-founder and CEO of DeepMind, the world’s leading AI research company, and Prof. Amnon Shashua, CEO and co-founder of Mobileye, the largest ever Israeli acquisition whose technology powers more than 55 million cars around the world today. Dr. Hassabis and Prof. Shashua will enlighten us on the potential of AI at an exclusive event in conjunction with the Dan David Prize on Monday, November 23, 2020.”

Video. Japan made robo-wolves to frighten off bears.

Pretty creative! 😃


The town of Takikawa on the northern island of Hokkaido purchased and installed a pair of the robots after bears were found roaming neighbourhoods in September. City officials said there have been no bear encounters since they deployed the robotic red-eyes blonde animal guardians were deploying ed to the city.

Original Article: http://www.dailymail.co.uk/sciencetech/article-8937567/Japanese-town-deploys-Monster-Wolf-robots-deter-wild-bears.html
Original Video: http://www.dailymail.co.uk/video/news/video-2290544/Video-Japanese-town-uses-robotic-wolf-scare-bears.html

Daily Mail Facebook: http://facebook.com/dailymail
Daily Mail IG: http://instagram.com/dailymail
Daily Mail Snap: https://www.snapchat.com/discover/Daily-Mail/8392137033
Daily Mail Twitter: http://twitter.com/MailOnline
Daily Mail Pinterest: http://pinterest.co.uk/dailymail
Daily Mail Google+: https://plus.google.com/+DailyMail

Get the free Daily Mail mobile app: http://dailymail.co.uk/mobile

Article from carbuzz.com. Was this human or AI error?


Semi-autonomous driving systems continue to come under the microscope, and the results are mixed. Tesla’s Autopilot system is one of the more well-known examples, and while some drivers like this Model 3 owner have faith in the technology, we have seen some disturbing instances of the system potentially leading to serious crashes.

Well, yet another Tesla was involved in a nasty crash and is a reminder that humans and driving aids don’t always make a safe combination. The video — recorded by the car’s camera system — was shared by GreenTheOnly on Twitter, a hacker who has previously uncovered some of the shortcomings of Tesla’s in-car tech. It’s not known what Tesla model this was.

Skeptical. But, wonder if will trigger major funding boost if true.


Any credible list of influential books about tech from the last decade would include AI Superpowers: China, Silicon Valley and the New World Order by Kai-Fu Lee. Considered the world’s foremost authority on artificial intelligence, Taipei-born Lee got an early start, writing a pioneering speech-recognition program while a student at Carnegie Mellon in the 1980s. He later had a career in China and the U.S. at Apple, Microsoft, Silicon Graphics and Google, where he was president of Google China. Now based in Beijing, Lee runs a venture capital firm called Sinovation, which focuses on AI investments. The interview with Lee took place (virtually) in early October.

Forbes Asia: AI Superpowers made you a global business star. Why did you write the book?

Kai-Fu Lee: China has—thanks to data, AI, and the entrepreneur ecosystem—rapidly evolved from a copycat into a true innovator. It currently co-leads artificial intelligence with the United States. When AI Superpowers came out in 2018, I think it was a bit surprising to people.

Would you be okay to have these injected in you?


Engineers at Cornell University developed a microscopic robot – so small it’s invisible to the naked eye – that walks. It’s so tiny that ten could fit within a period. The team says they can manufacture one million of the robots per week.

The new robot is essentially a microchip on four origami-inspired legs that can be activated by lasers. It was designed to crawl inside the human body, find and eliminate diseases. It can be steered by beaming a laser at its feet, which causes their leg to bend.

Itai Cohen and Paul McEuen Labs, leaders of this invention, envisions them as a beneficial medical tool to do things like hunt down and destroy cancer cells. The micro-bots are so small they can be injected into the body.